| Literature DB >> 35997351 |
Yoshiaki Matsushima1, Masako Kitano2, Daisuke Hayashi3, Hiroyuki Goto1, Mako Mine3, Takeshi Yokoe4, Makoto Kondo1, Koji Habe1, Yuji Toiyama4, Takashi Hashimoto3, Daisuke Tsuruta3, Kazuhiko Takeuchi2, Keiichi Yamanaka1.
Abstract
A 76-year-old Japanese man presented with a 6-year history of a sore throat. He was treated at several clinics without any improvement before being referred to us. Physical examination revealed widespread erosions and ulcers from the palate to the larynx. Approximately 25 × 15 mm in size, erosive lesions were present on the retroauricular regions, forearms, and glans penis. Pseudomembranous conjunctivitis was also observed. The skin biopsy revealed a partial cleft formation below the epidermis, suggesting subepidermal bullous disease. Immuno-serological tests were negative for anti-desmoglein 1 (Dsg1), anti-Dsg3, anti-BP180, and anti-BP230 antibodies by ELISAs. A whole-body examination revealed gastric cancer. The possibility of mucous membrane pemphigoid (MMP) or paraneoplastic pemphigus (PNP) was considered. Indirect immunofluorescence using rat bladders showed positive IgG reactivity with cell surfaces on the transitional epithelia. Immunoblotting using recombinant proteins of laminin-332 showed both IgG and IgA reactivities with laminin-α3, and immunoblotting using normal human epidermal extract showed double-positive reactivities with envoplakin and periplakin for both IgG and IgA antibodies. Based on the clinical and histopathological features and results of various immuno-serological tests, our case was diagnosed as anti-laminin-332-type MMP with serological findings of PNP. Twenty days after laparoscopic gastrectomy, treatment with oral methylprednisolone 32 mg/day was initiated, and mucosal and skin lesions improved.Entities:
Keywords: anti-laminin-332; envoplakin; laminin-α3; mucous membrane pemphigoid; periplakin
Year: 2022 PMID: 35997351 PMCID: PMC9397087 DOI: 10.3390/dermatopathology9030034
Source DB: PubMed Journal: Dermatopathology (Basel) ISSN: 2296-3529
Figure 1Clinical and histopathological findings. (a) The hard palate presented with erosion and ulcers. Erosions and ulcers were also present on the gingivae, the floor of the mouth, and from the pharynx to the esophagus. (b) An approximately 25 × 15 mm refractory erosive lesion observed on the retroauricular regions. (c) Pseudomembranous conjunctivitis and hyperemic conjunctiva. The upper eyelid adhered to the conjunctiva bulbi and could not be inverted. (d) Histopathology for the skin biopsy from left forearm showed subepidermal vesiculation and cleft formation at the dermo-epidermal junction. In the uppermost dermis, there was an inflammatory cell infiltrate mainly of neutrophils with a few lymphocytes and eosinophils (hematoxylin-eosin staining; scale bar = 100 μm). (e) Gastroscopy detected a gastric cancer, 35 × 24 mm in size, which was histologically a well-differentiated adenocarcinoma.
Figure 2Immuno-serological findings (a) Left: indirect immunofluorescence using rat bladder showed IgG reactivity with cell surfaces of the transitional epithelia in this patient (white arrows, serum dilution ×40). Center: negative control. Right: positive control. (b) The results of immunoblotting using recombinant proteins of laminin-332. Normal control serum showed no specific reactivity for both IgG and IgA (lane 1, 2). IgG antibodies of control anti-laminin-332 MMP serum reacted with the 165 kDa laminin-α3, 145 kDa laminin-β3, and 105 kDa laminin-γ2 (lane 3). IgG and IgA antibodies in our case’s serum reacted with the 165 kDa laminin-α3 (lane 4,5). (c) The results of immunoblotting using normal human epidermal extract. Normal control serum showed no specific reactivity (lanes 1,2). Control bullous pemphigoid (BP) sera reacted with the 180 kDa BP180 and 230 kDa BP230 (lanes 3,4). Specific monoclonal antibodies (mAbs) reacted with 160 kDa desmoglein 1 (Dsg1) (lane 5), the 130 kDa Dsg3 (lane 6), the 111 kDa and 103 kDa desmocollin 1 (Dsc1) (lane 8), and the 109 kDa and 100 kDa Dsc3 (lane 9). Control PNP serum reacted with the 210 kDa envoplakin and the 190 kDa periplakin (lane 7). IgG and IgA antibodies in our patient’s serum reacted with envoplakin and periplakin (lanes 10,11). IgG antibodies in our case’s serum also reacted with Dsc3 (lane 10).